UBS raised the firm’s price target on Dillard’s (DDS) to $170 from $150 and keeps a Sell rating on the shares. Dillard’s Q1 comp sales decline and elevated inventories reinforce the firm’s view that near-term earnings should remain under pressure, the analyst tells investors in a research note. UBS forecasts a (17%) five-year EPS compound annual growth rate and expects continuous EPS declines.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DDS:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue